MHUA
Meihua International Medical Technologies Co Ltd
NASDAQ: MHUA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$7.61
+0.00% today
Updated 2026-04-30
Market cap
$425.43M
P/E ratio
0.25
P/S ratio
4.75x
EPS (TTM)
$31.00
Dividend yield
—
52W range
$2 – $64
Volume
0.1M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F8.5
Quality
A5.5
Profitability
C+6.3
Valuation
B2/9
Piotroski F-Score
Weak
5.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
$6.20
-18.53%
Intrinsic (DCF)
$6.87
Margin of safety
-10.77%
Price chart
X-Ray snapshot
Strengths
+ Altman Z 5.83 — safe zone
+ Debt/equity 0.07x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Negative free cash flow $-19.81M
- Revenue declining -16.20% QoQ
- 10.77% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $104.04M | $103.35M | $97.10M | $96.91M | $89.55M |
| Net income | $19.99M | $6.24M | $11.63M | $10.84M | $3.15M |
| EPS | — | — | — | — | $31.00 |
| Free cash flow | $-904894.00 | $-11.86M | $-2.41M | $14.50M | $-19.81M |
| Profit margin | 19.22% | 6.04% | 11.97% | 11.19% | 10.30% |
Peer comparison
Smart narrative
Meihua International Medical Technologies Co Ltd trades at $7.61. representing a P/E of 0.25x trailing earnings. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 5.83, it sits in the safe zone. TTM revenue stands at $89.55M. with profit margins at 10.30%. Our DCF model estimates intrinsic value at $6.87.
Frequently asked questions
What is Meihua International Medical Technologies Co Ltd's stock price?
Meihua International Medical Technologies Co Ltd (MHUA) trades at $7.61.
Is Meihua International Medical Technologies Co Ltd overvalued?
Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $6.87.
What is the price target of Meihua International Medical Technologies Co Ltd (MHUA)?
The analyst target price is $—, representing NaN% downside from the current price of $7.61.
What is the intrinsic value of Meihua International Medical Technologies Co Ltd (MHUA)?
Based on our DCF model, intrinsic value is $6.87, a -10.8% margin of safety versus $7.61.
What is Meihua International Medical Technologies Co Ltd's revenue?
TTM revenue is $89.55M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
5.83 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.75x
ROE5.90%
Beta0.75
50D MA$19.26
200D MA$33.73
Shares out0.06B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week+0.00%
1 month+0.00%
3 months+0.00%
YTD+0.00%
1 year—
3 years—
5 years—